Qaiser Bashir
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qaiser Bashir as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06207799 · Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaM.D. Anderson Cancer Center · recruiting · Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging · principal investigator
- Ph2NCT05091372 · Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaM.D. Anderson Cancer Center · recruiting · Myeloma Multiple · principal investigator
- Ph2NCT04317781 · Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell TransplantM.D. Anderson Cancer Center · terminated · Blastic Plasmacytoid Dendritic Cell Neoplasm · principal investigator
- Ph1/Ph2NCT03417284 · Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell TransplantationM.D. Anderson Cancer Center · completed · Plasma Cell Myeloma · principal investigator
- N/ANCT01927718 · Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)M.D. Anderson Cancer Center · terminated · Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:20 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.Biol Blood Marrow Transplant · 2012203 citationsRCR 6.1
- Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.Biol Blood Marrow Transplant · 2014183 citationsRCR 6.1
- Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.Br J Haematol · 2017177 citationsRCR 5.3
- 110 citationsRCR 3.1
- 84 citationsRCR 5.8
- 75 citationsRCR 2.9
- Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.Lancet Haematol · 201975 citationsRCR 3.1
- 71 citationsRCR 1.9
- Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.Biol Blood Marrow Transplant · 201358 citationsRCR 1.8
- Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.J Clin Oncol · 202154 citationsRCR 3.4